Has Peter Harvey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,723 in general payments to Peter Harvey, MD across 122 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Harvey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Harvey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Harvey, MD

Orthopaedic Surgery of the Spine · Morrow, GANPI 1316934763

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,461 of the $6,723 with a category attached, or 66.4%. It is spread thinly across 17 manufacturers, the largest accounting for just 23.3%. Reporting peaked in 2021 at $1,884 and has fallen 51.6% since, to $912 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in GA, where the typical reported total is $16,983.

$6,723in general payments, 2019–2025

Across 122 payments — averaging $55.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Si-bone, Inc.$2K
Boston Scientific$2K
Curonix LLC$2K
Biotronik NRO, Inc.$738
Abbott$384
Medtronic$263
plus $709 from 11 others

What the payments were for

Travel & lodging$2,24633%
Food & beverage$4,46166%
Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Si-bone, Inc.	56	$1,564
Boston Scientific	18	$1,535
Curonix LLC	13	$1,530
Biotronik NRO, Inc.	5	$738
Abbott	9	$384
Medtronic(2 entities)	5	$263
Painteq LLC	4	$210
Nevro Corp.	2	$201
Saluda Medical Americas, Inc.	1	$85
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$71
Johnson & Johnson	1	$36
Pacira Therapeutics, Inc.	2	$34
Bioventus LLC	1	$18
Titan Spine, LLC	1	$16
Zyla Life Sciences, Inc.	1	$14
Stryker	1	$13
Dynasplint Systems Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$1,084
WAVEWRITER ALPHA$749
Prospera$607
iFuse Implant$138
Proclaim IPG$129
INTELLIS ADAPTIVESTIM$118
GENERAL PAIN MANAGEMENT$112
Omnia$109
INTELLIS$106

How this compares

$6,723 in reported general payments places this provider in the 35th percentile of 57 orthopaedic surgery of the spine providers in Georgia.

See all orthopaedic surgery of the spine providers in Georgia →

Medicare billing

Part B allowed, 2024

$137,723

Medicare patients

408

Services billed

4,185

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	327	$8,143
Celecoxib	357	$6,745
Gabapentin	158	$2,101
Tizanidine Hcl	182	$1,864
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	97	$970
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	67	$823
Tramadol Hcl	166	$601
Meloxicam	221	$600
Ketorolac Tromethamine	42	$525
Methylprednisolone	109	$434
Etodolac	16	$320
Ondansetron OdtOndansetron	19	$316
Acetaminophen-CodeineAcetaminophen With Codeine	29	$315
Baclofen	17	$221
Ondansetron Hcl	17	$122

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Morrow

John HellerAtlanta$4.2M
Scott BodenAtlanta$1.5M
Justin BundyAugusta$1.4M
John RheeAtlanta$1.1M
Tapan DaftariAustell$759K
Brad PrybisStockbridge$659K
Paul JeffordsAtlanta$651K
Raphael RoybalSavannah$400K
Hewatt SimsDouglas$376K
James MalcolmMarietta$295K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →